STANDEX INTERNATIONAL CORP

Standex insider Thomas Chorman sold 50 shares under a 10b5‑1 plan—steady, rising prices but no alarm. The move keeps the stock on a bullish trajectory, offering investors a clear view of its disciplined trading and solid growth prospects.

Thomas Chorman’s June sale of 50 Standex shares is a routine 10‑b‑5 move—minimal impact on the stock, yet worth noting for its liquidity strategy amid a 89% YTD rally.

Insider selling at Standex signals potential shifts—learn what Thomas Chorman’s recent 10‑b‑5‑1 trade means for investors and the company’s future.

Insider 10‑b‑5‑1 sales show Dunbar’s confidence: a modest 1 % discount, disciplined liquidity strategy, and potential impact on future volatility.

Standex insider sale: Thomas Chorman sells 50 shares under a planned 10‑billion‑dollar plan, hinting at cautious confidence in SXI’s medium‑term prospects.

Standex insider buy: Andy Németh adds 2,000 shares, reinforcing confidence in the company’s growth‑oriented industrial‑machinery platform.